secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sigyn Therapeutics, Inc. (SIGY)
CIK:        0001642159
Form:       8-K
Filed at:   2023-12-12T23:59:59+00:00
Accession:  0001493152-23-044529
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sigyn Therapeutics removes CFO Jeremy Ferrell, appoints Jerry DeCiccio as replacement
--------------------------------------------------------------------------------

- Jeremy Ferrell removed as CFO effective immediately; no disagreements cited.
- Jerry DeCiccio appointed CFO effective immediately; he is a CPA with 40+ years experience.
- DeCiccio most recently served as a consultant; holds BA from Loma Linda and MBA from USC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642159/000149315223044529/0001493152-23-044529-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642159/000149315223044529/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-044529

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer